Company intelligence / Profile preview

Actio Biosciences

San Diego, California, United Statesactiobiosciences.com ↗
Ownership
Private
Employees
~50
Development stage
Phase 1
01

Overview

The company is developing a TRPV4 program for CMT2C and other bone diseases, along with two additional programs for genetic epilepsies and genetic skin conditions. No specific clinical results mentioned yet.

Therapeutic areas
DermatologyRheumatologyRare DiseasesNeurology
Modalities
therapeutics
Industry
Biotech
02

Drug pipeline

3 assets

ABS-1230

2

2 more assets in the full pipeline.

03

Partnerships

The Jackson Laboratory

Beyond the preview

Go deeper on Actio Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actio Biosciences.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call